EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
153 hedge funds and large institutions have $337M invested in Eagle Pharmaceuticals, Inc. in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 63 increasing their positions, 47 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
153
Holding in Top 10
–
Calls
$3.6M
Puts
–
Top Buyers
| 1 | +$27.5M | |
| 2 | +$6.23M | |
| 3 | +$3.29M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.16M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$3.14M |
Top Sellers
| 1 | -$3.97M | |
| 2 | -$3.75M | |
| 3 | -$3.25M | |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$3.17M |
| 5 |
E
Ergoteles
New York
|
-$2.03M |